Adagene (NASDAQ:ADAG) Stock, Quote.Headers.trade-ideas

Adagene

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADAG

ATPC

DRMA

EGIO

ENTO

IOBT

ITOS

LDTC

NCNA

PPBT

PTIX

SQFT

TNON

XCUR

Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket

Penny Stocks

Small Cap

Intraday Update

ABSI

AGAE

AGFY

ALLY

ASTS

AXDX

AZTR

BCDA

BFRG

CELH

CHGG

CISS

CRGE

DTSS

ESPR

EWTX

GOOG

GOOGL

IRBT

KAMN

MESA

MESO

Morgan Stanley Capital Protected Notes for S&P 500 Index

NAMS

NKTX

ORGS

PCSA

PRTG

RNAZ

SAVE

SHPH

SILK

SMCI

SOAR

VMAR

WRLD

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session.

TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share.

TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.

Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

ABAT

ACIC

ACXP

ALEC

CART

CGTX

COMP

CVGW

DOCN

DWAC

FTEL

HOVR

Kintara Therapeutics, Inc. - Common Stock

KTRA

LQDA

MARK

Airspan Networks Holdings Inc. Common Stock

MIMO

MNSO

NUKK

PHUN

PRGS

PRQR

ROMA

RVSN

SBGI

SEDG

SHOT

TELL

TREE

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announced a partnership with GCT Semiconductor to develop an RF module.

Airspan Networks Holdings shares surged 381% to $0.3699 on Wednesday.

Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Adagene Inc. - ADS, each representing 1.25 ordinary shares

Adagene Inc

Adagio Medical Holdings, Inc - Common Stock

Adagio Medical Holdings Inc

Press Releases

Adagene to Host Virtual KOL Event to Discuss Anti-CTLA-4 SAFEbody® ADG126 in Advanced/Metastatic Microsatellite-Stable (MSS) Colorectal Cancer (CRC) on January 25, 2025

Health Care

Adagene to Announce Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium

General

Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium

Adagene Announces Investigator Initiated Phase 2 Trial for Neoadjuvant Muzastotug (ADG126) in Colorectal Cancer

Adagene to Present at Leerink's Global Healthcare Conference 2025

Adagene to Present at 11th Annual Immuno-Oncology 360⁰ Summit

Earnings

Adagene Reports Full Year 2024 Financial Results and Provides Corporate Update

Adagene to Present at Stifel's 2025 Virtual Targeted Oncology Forum

Adagene Announces Upcoming Poster Presentation on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at American Society of Clinical Oncology (ASCO) Annual Meeting

Management

Adagene Appoints John Maraganore, Ph.D. as Executive Advisor

Anixa Biosciences

Cabaletta Bio

Cibus

Coherus BioSciences

Climb Bio

Corbus Pharmaceuticals Holdings, Inc. - Common Stock

Corbus Pharmaceuticals

Caribou Biosciences

CervoMed

Elicio Therapeutics

Galectin Therapeutics Inc. - Common Stock

Galectin Therapeutics

Genelux

Genenta Science S.p.A. - American Depositary Shares

Genenta Science

Inozyme Pharma

Invivyd

Jasper Therapeutics, Inc. - Class A Common Stock

Jasper Therapeutics

Lexeo Therapeutics

OncoCyte

Sera Prognostics, Inc. - Class A Common Stock

Sera Prognostics

Senti Biosciences

Sutro Biopharma

TScan Therapeutics

Whitehawk Therapeutics, Inc. - Common Stock

Whitehawk Therapeutics

XBiotech

Zentalis Pharmaceuticals, Inc. - common stock

Zentalis Pharma

Zura Bio Limited - Class A Ordinary shares

Zura Bio

HC Wainwright & Co.

Morgan Stanley

Comments

Adagene

Adagene (NASDAQ:ADAG) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell